| Year |
Citation |
Score |
| 2024 |
Drane DL, Acerbo E, Rogers A, Pedersen NP, Williamson A, Stern MA, Dickey AS, Howard BM, Bearden DJ, Okada N, Staikova E, Gutekunst CA, Alwaki A, Gershon T, Jirsa V, et al. Selective Posterior Cerebral Artery Wada Better Predicts Good Memory and Naming Outcomes Following Selective Stereotactic Thermal Ablation for Medial Temporal Lobe Epilepsy Than Internal Carotid Artery Wada. Medrxiv : the Preprint Server For Health Sciences. PMID 38585976 DOI: 10.1101/2024.03.24.24304488 |
0.34 |
|
| 2024 |
Stern MA, Cole ER, Gross RE, Berglund K. Seizure event detection using intravital two-photon calcium imaging data. Neurophotonics. 11: 024202. PMID 38274784 DOI: 10.1117/1.NPh.11.2.024202 |
0.338 |
|
| 2023 |
Stern MA, Cole ER, Gross RE, Berglund K. Seizure Event Detection Using Intravital Two-Photon Calcium Imaging Data. Biorxiv : the Preprint Server For Biology. PMID 37808822 DOI: 10.1101/2023.09.28.558338 |
0.341 |
|
| 2022 |
Stern MA, Skelton H, Fernandez AM, Gutekunst CN, Gross RE, Berglund K. Applications of Bioluminescence-Optogenetics in Rodent Models. Methods in Molecular Biology (Clifton, N.J.). 2525: 347-363. PMID 35836082 DOI: 10.1007/978-1-0716-2473-9_27 |
0.418 |
|
| 2022 |
Stern MA, Skelton H, Fernandez AM, Gutekunst CN, Berglund K, Gross RE. Bioluminescence-Optogenetics: A Practical Guide. Methods in Molecular Biology (Clifton, N.J.). 2525: 333-346. PMID 35836081 DOI: 10.1007/978-1-0716-2473-9_26 |
0.428 |
|
| 2021 |
William CM, Stern MA, Pei X, Saqran L, Ramani M, Frosch MP, Hyman BT. Impairment of visual cortical plasticity by amyloid-beta species. Neurobiology of Disease. 154: 105344. PMID 33766652 DOI: 10.1016/j.nbd.2021.105344 |
0.553 |
|
| 2021 |
Berglund K, Stern MA, Gross RE. Bioluminescence-Optogenetics. Advances in Experimental Medicine and Biology. 1293: 281-293. PMID 33398820 DOI: 10.1007/978-981-15-8763-4_17 |
0.4 |
|
| 2020 |
Stern MA, Isbaine F, Qiu D, Riley JP, Boulis NM, Gross RE. Radiofrequency ablation through previously effective deep brain stimulation leads for Parkinson's disease: A retrospective series. World Neurosurgery. PMID 32949803 DOI: 10.1016/J.Wneu.2020.09.060 |
0.449 |
|
| 2020 |
Stern MA, Malcolm JG, Willie JT, Gross RE, Drane DL. Letter: Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Epilepsy: Systematic Review of Technique, Indications, and Outcomes. Neurosurgery. PMID 32615597 DOI: 10.1093/Neuros/Nyaa274 |
0.495 |
|
| 2019 |
Willie JT, Malcolm JG, Stern MA, Lowder LO, Neill SG, Cabaniss BT, Drane DL, Gross RE. Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations. Epilepsia. PMID 30653657 DOI: 10.1111/Epi.14634 |
0.497 |
|
| 2018 |
Gross RE, Stern MA. Magnetic resonance-guided stereotactic laser pallidotomy for dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29701309 DOI: 10.1002/Mds.27400 |
0.473 |
|
| 2018 |
Gross RE, Stern MA, Willie JT, Fasano RE, Saindane AM, Soares BP, Pedersen NP, Drane DL. Stereotactic Laser Amygdalohippocampotomy for Mesial Temporal Lobe Epilepsy. Annals of Neurology. PMID 29420840 DOI: 10.1002/Ana.25180 |
0.488 |
|
| 2017 |
William CM, Saqran L, Stern MA, Chiang CL, Herrick S, Rangwala A, Albers MW, Frosch MP, Hyman BT. Activity-dependent dysfunction in visual and olfactory sensory systems in mouse models of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28899917 DOI: 10.1523/Jneurosci.1045-17.2017 |
0.567 |
|
| 2010 |
Langford DJ, Tuttle AH, Brown K, Deschenes S, Fischer DB, Mutso A, Root KC, Sotocinal SG, Stern MA, Mogil JS, Sternberg WF. Social approach to pain in laboratory mice. Social Neuroscience. 5: 163-70. PMID 19844845 DOI: 10.1080/17470910903216609 |
0.246 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2003 |
Siderowf A, Stern M. Update on Parkinson disease. Annals of Internal Medicine. 138: 651-8. PMID 12693888 DOI: 10.7326/0003-4819-138-8-200304150-00013 |
0.14 |
|
| 2005 |
Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. Journal of Neurosurgery. 103: 956-67. PMID 16381181 DOI: 10.3171/jns.2005.103.6.0956 |
0.134 |
|
| 2015 |
Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 622-9. PMID 25185211 DOI: 10.1136/Jnnp-2014-308119 |
0.13 |
|
| 2013 |
Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. The Lancet. Neurology. 12: 514-24. PMID 23582175 DOI: 10.1016/S1474-4422(13)70047-4 |
0.123 |
|
| 2010 |
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 362: 2077-91. PMID 20519680 DOI: 10.1056/Nejmoa0907083 |
0.119 |
|
| 2010 |
Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, ... Stern M, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet. Neurology. 9: 1164-72. PMID 20970382 DOI: 10.1016/S1474-4422(10)70254-4 |
0.117 |
|
| 2011 |
Rascol O, Lozano A, Stern M, Poewe W. Milestones in Parkinson's disease therapeutics. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1072-82. PMID 21626552 DOI: 10.1002/Mds.23714 |
0.114 |
|
| 2012 |
Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 79: 55-65. PMID 22722632 DOI: 10.1212/Wnl.0B013E31825Dcdc1 |
0.113 |
|
| 2009 |
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama. 301: 63-73. PMID 19126811 DOI: 10.1001/Jama.2008.929 |
0.111 |
|
| 2010 |
Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2099-104. PMID 20669288 DOI: 10.1002/Mds.23234 |
0.11 |
|
| 2024 |
Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, ... ... Stern M, et al. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. The Lancet. Neurology. 23: 178-190. PMID 38267190 DOI: 10.1016/S1474-4422(23)00405-2 |
0.107 |
|
| 2006 |
Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease. Movement Disorders. 21: 746-753. PMID 16463342 DOI: 10.1002/Mds.20786 |
0.106 |
|
| 2015 |
Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, ... ... Stern M, et al. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Annals of Neurology. 78: 248-57. PMID 26061140 DOI: 10.1002/Ana.24436 |
0.102 |
|
| 2021 |
Rothlind JC, York MK, Luo P, Carlson K, Marks WJ, Weaver FM, Stern M, Follett KA, Duda JE, Reda DJ. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism & Related Disorders. 95: 23-27. PMID 34974395 DOI: 10.1016/j.parkreldis.2021.12.011 |
0.1 |
|
| 2024 |
Stern MA, Dingledine R. One Ring to Bind Them: The Annulus of GABAergic Inhibitory Restraint Fades at Seizure Emergence. Epilepsy Currents. 24: 53-55. PMID 38327527 DOI: 10.1177/15357597231223586 |
0.092 |
|
| 2011 |
Halliday G, Lees A, Stern M. Milestones in Parkinson's disease--clinical and pathologic features. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1015-21. PMID 21626546 DOI: 10.1002/mds.23669 |
0.089 |
|
| 2013 |
Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, Stern M, Follett KA, Reda D, Weaver FM. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1113-8. PMID 23667214 DOI: 10.1136/jnnp-2012-304396 |
0.088 |
|
| 2014 |
Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology. 83: 1739-46. PMID 25298306 DOI: 10.1212/Wnl.0000000000000960 |
0.086 |
|
| 2021 |
Tropea TF, Amari N, Han N, Rick J, Suh E, Akhtar RS, Dahodwala N, Deik A, Gonzalez-Alegre P, Hurtig H, Siderowf A, Spindler M, Stern M, Thenganatt MA, Weintraub D, et al. Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study. Journal of Parkinson's Disease. PMID 33492247 DOI: 10.3233/JPD-202406 |
0.085 |
|
| 2010 |
Watts RL, Lyons KE, Pahwa R, Sethi K, Stern M, Hauser RA, Olanow W, Gray AM, Adams B, Earl NL. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 858-66. PMID 20461803 DOI: 10.1002/mds.22890 |
0.084 |
|
| 2016 |
Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, ... Stern M, et al. The new definition and diagnostic criteria of Parkinson's disease. The Lancet. Neurology. 15: 546-8. PMID 27302120 DOI: 10.1016/S1474-4422(16)00116-2 |
0.083 |
|
| 2016 |
Hu J, Stern M, Gimenez LE, Wanka L, Zhu L, Rossi M, Meister J, Inoue A, Beck-Sickinger AG, Gurevich VV, Wess J. A G Protein-Biased Designer G Protein-Coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-Dependent Signaling Pathways. The Journal of Biological Chemistry. PMID 26851281 DOI: 10.1074/Jbc.M115.702282 |
0.083 |
|
| 2016 |
Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease. Parkinsonism & Related Disorders. PMID 26923524 DOI: 10.1016/J.Parkreldis.2016.02.020 |
0.083 |
|
| 2020 |
Siderowf A, Jennings D, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32657461 DOI: 10.1002/Mds.28139 |
0.082 |
|
| 2017 |
Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. Jama Neurology. PMID 28595287 DOI: 10.1001/Jamaneurol.2017.0985 |
0.081 |
|
| 2015 |
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, ... ... Stern M, et al. MDS research criteria for prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1600-11. PMID 26474317 DOI: 10.1002/Mds.26431 |
0.08 |
|
| 2004 |
Liang L, Chinnathambi S, Stern M, Tomanek-Chalkley A, Manuel TD, Bickenbach JR. As epidermal stem cells age they do not substantially change their characteristics. The Journal of Investigative Dermatology. Symposium Proceedings / the Society For Investigative Dermatology, Inc. [and] European Society For Dermatological Research. 9: 229-37. PMID 15369218 DOI: 10.1111/J.1087-0024.2004.09309.X |
0.08 |
|
| 2006 |
Siderowf A, Stern M. Clinical trials with rasagiline: evidence for short-term and long-term effects. Neurology. 66: S80-8. PMID 16717255 DOI: 10.1212/WNL.66.10_SUPPL_4.S80 |
0.08 |
|
| 2024 |
Tropea TF, Hartstone W, Amari N, Baum D, Rick J, Suh E, Zhang H, Paul RA, Han N, Zack R, Brody EM, Albuja I, James J, Spindler M, Deik A, ... ... Stern M, et al. Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level. Npj Parkinson's Disease. 10: 97. PMID 38702337 DOI: 10.1038/s41531-024-00690-6 |
0.077 |
|
| 2006 |
deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I. Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1716-21. PMID 16856145 DOI: 10.1002/Mds.21048 |
0.075 |
|
| 2006 |
Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Archives of Neurology. 63: 210-6. PMID 16476809 DOI: 10.1001/Archneur.63.2.210 |
0.074 |
|
| 2015 |
Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26249849 DOI: 10.1002/Mds.26339 |
0.073 |
|
| 2005 |
Robinson K, Dennison A, Roalf D, Noorigian J, Cianci H, Bunting-Perry L, Moberg P, Kleiner-Fisman G, Martine R, Duda J, Jaggi J, Stern M. Falling risk factors in Parkinson's disease Neurorehabilitation. 20: 169-182. PMID 16340098 DOI: 10.3233/Nre-2005-20304 |
0.071 |
|
| 2014 |
Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, ... ... Stern M, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 454-62. PMID 24619848 DOI: 10.1002/Mds.25844 |
0.066 |
|
| 2020 |
Kreuzer M, Stern MA, Hight D, Berger S, Schneider G, Sleigh JW, García PS. Spectral and Entropic Features Are Altered by Age in the Electroencephalogram in Patients under Sevoflurane Anesthesia. Anesthesiology. PMID 32108685 DOI: 10.1097/Aln.0000000000003182 |
0.066 |
|
| 2002 |
Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/Archneur.59.10.1541 |
0.065 |
|
| 2012 |
Dahodwala N, Karlawish J, Shea JA, Zubritsky C, Stern M, Mandell DS. Validation of an instrument to measure older adults' expectations regarding movement (ERM). Plos One. 7: e43854. PMID 22937110 DOI: 10.1371/journal.pone.0043854 |
0.064 |
|
| 2014 |
Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 83: 826-33. PMID 25037206 DOI: 10.1212/Wnl.0000000000000729 |
0.064 |
|
| 2018 |
Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, ... Stern M, et al. Movement disorder society criteria for clinically established early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145841 DOI: 10.1002/Mds.27431 |
0.062 |
|
| 2005 |
Follett K, Weaver F, Stern M, Marks W, Hogarth P, Holloway K, Bronstein J, Duda J, Horn S, Lai E, Samii A, Okun MS, Foote KD. Multisite randomized trial of deep brain stimulation [4] (multiple letters) Archives of Neurology. 62: 1643-1645. PMID 16216957 DOI: 10.1001/archneur.62.10.1643-b |
0.06 |
|
| 2006 |
Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23. PMID 16450340 DOI: 10.1002/Mds.20764 |
0.055 |
|
| 2021 |
Kostelnik C, Hohn J, Escoto-Diaz CE, Kooistra JB, Stern M, Swinton DE, Richardson W, Carver W, Eberth J. Small-diameter artery decellularization: Effects of anionic detergent concentration and treatment duration on porcine internal thoracic arteries. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. PMID 34855280 DOI: 10.1002/jbm.b.34969 |
0.053 |
|
| 2015 |
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1591-601. PMID 26474316 DOI: 10.1002/Mds.26424 |
0.053 |
|
| 2023 |
Shin J, Andrews M, DeJean L, Debski N, Exarchakis A, Fleming J, Gandhi R, Hum C, Kalladanthyil A, Maddigunta R, Napoli L, Nguyen C, Paul R, Schmalbach N, Sichel J, ... ... Stern M, et al. Risk Factors Associated With Atrial Fibrillation in Elderly Patients. Journal of Clinical Medicine Research. 15: 148-160. PMID 37035851 DOI: 10.14740/jocmr4884 |
0.052 |
|
| 2017 |
Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS. Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28906025 DOI: 10.1002/Mds.27127 |
0.043 |
|
| 2009 |
Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS. Racial differences in the diagnosis of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1200-5. PMID 19412929 DOI: 10.1002/mds.22557 |
0.042 |
|
| 2016 |
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, et al. Abolishing the 1-year rule: How much evidence will be enough? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27666574 DOI: 10.1002/Mds.26796 |
0.032 |
|
| 2018 |
Stern MA, Stern J, Dengler WC. The importance of standardizing testing of refractory esophageal disorders with EGD, pH testing, and high resolution manometry with impedance Neurogastroenterology & Motility. 30: e13343. DOI: 10.1111/nmo.13343 |
0.03 |
|
| 2015 |
Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Author Response. Neurology. 84: 2292. PMID 26230002 |
0.013 |
|
| Hide low-probability matches. |